Thuja Capital
Utrecht, Utrechtthujacapital.com
Overview
Thuja Capital is an independent venture capital firm specialized in investing in early-stage medical product companies in the Netherlands and Belgium. The firm seeks to invest in medical devices, medical technology, diagnostics, therapeutics, medical foods & nutraceuticals, and digital health sectors. It aims is to leverage science with entrepreneurship and capital, in order to accelerate innovative, affordable medical products to patients.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Tacalyx | Apr 2026 | Seed | Co-investor |
| ATRO Medical | Feb 2026 | Early Funding | Co-investor |
| Pan Cancer T | Dec 2025 | Debt | Co-investor |
| Salvia BioElectronics | May 2025 | Series B | Co-investor |
| Alesta Therapeutics | Jan 2025 | Series A | Co-investor |
Key People
Michel Briejer
Managing Partner
Eline van Beest
Operating Partner
Florian Ludwig
Venture Partner
Tyler F. Hayes
Principal
Nawal Bahia El I.
Member Of The Investor Board (TCHF III)
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
